In childhood, the main tumour risks are ACC, STS, osteosarcomas and CNS tumours whereas the main tumour risk in adults corresponds to female breast cancers, female TP53 variant carriers have an excessively high risk of developing breast cancer before 31. This evidence concerns the gene TP53 and central nervous system neoplasm.